Seryl-tRNA Synthetase (SARS) (C-Term) Antikörper
Kurzübersicht für Seryl-tRNA Synthetase (SARS) (C-Term) Antikörper (ABIN630017)
Target
Alle Seryl-tRNA Synthetase (SARS) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- SARS antibody was raised against the C terminal of SARS
-
Aufreinigung
- Purified
-
Immunogen
- SARS antibody was raised using the C terminal of SARS corresponding to a region with amino acids PEKLKEFMPPGLQELIPFVKPAPIEQEPSKKQKKQHEGSKKKAAARDVTL
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
SARS Blocking Peptide, (ABIN5615998), is also available for use as a blocking control in assays to test for specificity of this SARS antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SARS antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Seryl-tRNA Synthetase (SARS)
-
Andere Bezeichnung
- SARS
-
Hintergrund
- SARS belongs to the class II amino-acyl tRNA family. The enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts.
-
Molekulargewicht
- 57 kDa (MW of target protein)
Target
-